BJC MEDICAL GROUP SUPPORTS PHYSICIAN PRACTICES ASSOCIATED WITH BJC HEALTHCARE HOSPITALS AND HELPS THEM GROW. THE MEDICAL GROUP ALSO PARTNERS WITH PRIVATE PHYSICIANS AND BJC HOSPITALS TO RECRUIT PHYSICIANS TO GROWING MARKETS. PHYSICIAN RECRUITS INCLUDE BOTH PRIMARY AND SPECIALTY PHYSICIANS. THE ORGANIZATION...
Consensus guidelines from expert groups differ in their indications for treatment and the recommended route of administration. European Society for Medical Oncology (ESMO; [4]) and British Society of Hematology (BSH; [5]) recommend CNS prophylaxis in patients with high IPI or CNS-IPI or for thos...
An exploratory clinical trial examined the potential of including valganciclovir as an add-on to the standard of care therapy for patients with GB. There was no observed significant difference in tumour size and median OS between the treatment and placebo group. However, patients receiving more than...
In the case of human ESC lines there are special non-statutory regulations required under Medical Research Council (MRC) funding. These require that projects using hESC lines or their import, export or movement from one centre to another must have the approval of a national oversight body, the...
2Intercenter Cancer Research Group, Florida, 3Pacific Shores Medical Group, California. 4Medarex, Inc., New Jersey, USA. Aim: To evaluate the bispecific antibody MDX-H210 (which combines a recognition site for HER-2/neu with a triggering sequence for the high affinity IgG Fc receptor CD64)...
MEDICAL RESEARCH COUNCIL (1966). Working Party on the Evaluation of Different Methods of Therapy in Carcinoma of the Bronchus. Comparative trial of surgery and radiotherapy for the primary treatment of small celled or oat-celled carcinoma of the bronchus. Lancet, ii, 979. OSTERLIND, K., ...
women were managed according to the intervention group protocol. A detailed description of the management is available (Bulkmans et al, 2007;Rijkaart et al, 2012b). The POBASCAM trial was approved by the Medical Ethics Committee of the VU University Medical Centre (Amsterdam, the Netherlands;...
There are several reasons why this might be so: not all patients are entered into clinical trials, and those recruited to ST01 may have been healthier than anticipated; medical care may have changed over the years; 3 Smmgi.Sim h .-qmm mmcuswe PM Fayers and D Machti cases may be ...
Mr David Papworth, Medical Research Council Radiobiology Unit, Chilton, gave me statistical help. Dr G.J. Draper, Director, and Dr C.A. Stiller, Childhood Cancer Research Group, University of Oxford, kindly provided unpublished tables of national records of deaths from childhood cancer by year ...
serve as a good early biomarker for NSCLC detection and improve the clinical diagnostic efficiency of CEA. To further confirm our data analysis, a larger patient cohort for clinical application is required, especially if this is to be implemented for medical examination in the early screening of ...